Effect of Antimuscarinic Drugs on Cognitive Functions in the Management of Overactive Bladder in Elderly

被引:0
|
作者
Rangganata, Ervandy [1 ]
Widia, Fina [1 ]
Rahardjo, Harrina E. [1 ]
机构
[1] Univ Indonesia, Cipto Mangunkusumo Hosp, Fac Med, Dept Urol, Jl Diponegoro 71, Jakarta 10430, Indonesia
关键词
antimuscarinic drugs; cognitive functions; overactive bladder; mini-mental state examination (MMSE); DOUBLE-BLIND; OLDER; INCONTINENCE; FESOTERODINE; IMIDAFENACIN; TERMINOLOGY; CHLORIDE; THERAPY; SAFETY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: overactive bladder (OAB) affects 17-41% older adults in community dwelled setting. For several years, antimuscarinics have been validated as the first-line medical treatment for OAB. Despite abundant data obtained from clinical trials provisions the use of antimuscarinics, investigation about the effect of this drug on cognitive function in elderly remains scarce. The objective of this study is to investigate the effect of antimuscarinics therapy on cognitive functions in OAB geriatric patients. Methods: this study design is a .systematic review and meta-analysis. Studies were collected using several search engines; those were PubMed, Science Direct, Cochrane, and EBSCOhost using predetermined MeSH keywords with Boolean operators. Selection of studies was done by three reviewers. Studies which fulfilled the inclusion and exclusion criteria underwent full-text review. For every selected full text, we extracted the following data if available: patients demographics, types of antimuscarinics used, placebo, dose, follow-up period, and Mini-Mental State Examination (MMSE) total score. Results: a total of 8 studies from an initial 146 publications were selected. There were 8 antimuscarinic agents evaluated in the studies, including Oxybutynin, Darifenacin, Tolterodine, Trospium, Imidafenacin, Pmpiverine hydrochloride, Fesoterodine, and Solifenacin. Oxybutynin was shown to have largest effect towards the decline of MMSE score [Mean difference: -2.90; 95% CI: -4.07, -1.73]. Darifenacin and Tolterodine were also shown to be significant in the decline of total MMSE score, although still inferior to Oxybutynin. Conclusion: the use of most antimuscarinics medication has little to no effect towards the cognitive function in the management of overactive bladder in elderly patients. However, Oxybutynin, Darifenacin, and Tolterodine was shown to have significant decrease in cognitive functions, as shown in the decline of total MMSE score.
引用
收藏
页码:255 / 263
页数:9
相关论文
共 50 条
  • [31] Making a Case for Not Prescribing Antimuscarinic Drugs to Treat Overactive Bladder in Older Adults
    Chancellor, Michael B.
    Watanabe, Toyohiko
    JOURNAL OF UROLOGY, 2019, 201 (04): : 676 - 677
  • [32] Comparison of antimuscarinic drugs to beta adrenergic agonists in overactive bladder: A literary review
    Wani, Mudassir M.
    Sheikh, Mohammad I.
    Bhat, Tahir
    Bhat, Zubair
    Bhat, Arshad
    CURRENT UROLOGY, 2021, 15 (03) : 153 - 160
  • [33] Patterns of Use of Antimuscarinic Drugs for Overactive Bladder: A Study of the Norwegian Prescription Database
    Mauseth, Siri Ann
    Spigset, Olav
    Skurtveit, Svetlana
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 66 - 67
  • [34] Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions?
    Finney, Steven M.
    Andersson, Karl-Erik
    Gillespie, James I.
    Stewart, Laurence H.
    BJU INTERNATIONAL, 2006, 98 (03) : 503 - 507
  • [35] Solifenacin provides effective antimuscarinic therapy for the complete management of overactive bladder
    Chapple, Christopher R.
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (17) : 2421 - 2434
  • [36] Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom
    Margulis, Andrea V.
    Linder, Marie
    Arana, Alejandro
    Pottegard, Anton
    Berglind, Ina Anveden
    Bui, Christine L.
    Kristiansen, Nina Sahlertz
    Bahmanyar, Shahram
    McQuay, Lisa J.
    Atsma, Willem Jan
    Appenteng, Kwame
    D'Silva, Milbhor
    Perez-Gutthann, Susana
    Hallas, Jesper
    PLOS ONE, 2018, 13 (09):
  • [37] Re: Antimuscarinic Drug Therapy for Overactive Bladder Syndrome in the Elderly-Are the Concerns Justified?
    Wein, Alan J.
    JOURNAL OF UROLOGY, 2019, 202 (06): : 1103 - 1104
  • [38] Cardiovascular effects of antimuscarinic agents in overactive bladder
    Rosa, Gian Marco
    Bauckneht, Matteo
    Scala, Carolina
    Tafi, Emanuela
    Maggiore, Umberto Leone Roberti
    Ferrero, Simone
    Brunelli, Claudio
    EXPERT OPINION ON DRUG SAFETY, 2013, 12 (06) : 815 - 827
  • [39] Persistence with antimuscarinic therapy in patients with overactive bladder
    Haab, F
    Castro-Diaz, D
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (08) : 931 - 937
  • [40] Patterns of Use of Antimuscarinic Drugs to Treat Overactive Bladder in Denmark, Sweden and the United Kingdom
    Margulis, Andrea V.
    Linder, Marie
    Arana, Alejandro
    Pottegard, Anton
    Anveden-Berglind, Ingegard
    Bui, Christine L.
    Kristiansen, Nina
    Bahmanyar, Shahram
    McQuay, Lisa J.
    Atsma, Willem Jan
    Appenteng, Kwame
    Franks, Billy
    de Vogel, Stefan
    D'Silva, Milbhor
    Perez-Gutthann, Susana
    Hallas, Jesper
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 654 - 655